Viewing Study NCT04166006


Ignite Creation Date: 2025-12-26 @ 5:24 PM
Ignite Modification Date: 2026-02-21 @ 11:29 PM
Study NCT ID: NCT04166006
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2019-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module